Brighter announces commercial launch and availability of Actiste® in Qatar.
Brighter AB (Publ) (The Company) today announced the launch and commercial availability of its Actiste® service, aiming to improve the quality of life for people living with diabetes in Qatar. The company's distributor in Qatar – Al Danah Medical Company – has placed an initial order for a small number of Actiste® devices, which will shortly be shipped to the country. The value of the order is not material but besides being the first Actiste® devices that will be offered to diabetes patients in Qatar, the shipment is also a part of validating the processes that Brighter has in place –